Drug Profile
Entecavir orodispersible film - Abbott Healthcare
Alternative Names: BucretisLatest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator Abbott Healthcare
- Class Antivirals; Cyclopentanes; Hypoxanthines; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors; RNA-directed DNA polymerase inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 09 Jul 2019 Discontinued - Preclinical for Hepatitis B in Thailand (PO)
- 09 Jul 2019 Discontinued - Preregistration for Hepatitis B in Philippines (PO)
- 20 Jul 2017 Chemical structure information added